Featured Press Releases

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics

Dr. Jonathan Sadeh, ex-SVP of Immunology R&D at Bristol-Myers Squibb, joins Scinai Immunotherapeutics' Scientific Advisory Board

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)

BioMarin to Present Data Showcasing VOXZOGO® (vosoritide)'s Impact on Bone Health and Quality of Life in Achondroplasia

  • 17 Jun 2024

BioMarin Pharmaceutical Inc. announced the presentation of new data from an investigator-led...

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Improved Pharma Brings Onboard Micro-DSC Hot-Stage System

Onco360 now offers LAZCLUZE™ (lazertinib) with Rybrevant® for first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations

Onco360 now offers LAZCLUZE™ (lazertinib) with Rybrevant® for first-line treatment of metastatic non-small cell lung cancer with specific EGFR mutations

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

Dr. Alastair Leighton, a biopharma veteran, has been hired as Chief Operating Officer by Chemify

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

With timsOmni™ Mass Spectrometry, Bruker Advances Functional Proteomics 2.0 for Deeper Insights into Disease Biology

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

Eli Lilly’s Foundayo™: The Newest GLP-1 Innovation Offered by Ro

  • Ro
  • 09 Apr 2026
Approval and Launch of Nintedanib Capsules

Approval and Launch of Nintedanib Capsules

  • Dexcel Pharma USA
  • 09 Apr 2026
When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

When Every Beat Matters, BD Helps Clinicians Gain Continuous, Noninvasive Blood Pressure Insight to Eliminate Blind Spots

  • BD
  • 07 Apr 2026
Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

Dr. Amit Singal Appointed as Chief Medical Officer by Curve Biosciences

  • Curve Biosciences
  • 07 Apr 2026
MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

MEDIPEEL Gains Momentum in the K-Pharmacy Channel in Korea.

  • MEDIPEEL
  • 06 Apr 2026
Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

Epia Neuro Launches Intent-Driven Neural Technology to Restore Function After Stroke and Address Cognitive Decline

  • Epia Neuro
  • 06 Apr 2026
Drug Discovery 2024
The Digital Pharma Advances Conference 2026

Most Popular
April   2026
M T W T F S S
    1 2 3 4 5
6 7 8 9 10 11 12
13 14 15 16 17 18 19
20 21 22 23 24 25 26
27 28 29 30      

User Area

Discover

Engage with Us

© Pharmaceutical Era — A product of HISSM. All Rights Reserved.